3658 results for «247»
3658 results
Tailored device choice and implant technique to optimise TAVI procedural outcomes
17 May 2023 – From EuroPCR 2023
Discover the key factors to consider in selecting the optimal valve and implant technique for transcatheter aortic valve implantation (TAVI) to achieve optimal procedural outcomes. Gain insights into the impact of device choice and implantation technique on coronary access following TAVI and learn valuable strategies for...
STEMI and unusual thrombus
16 May 2023 – From EuroPCR 2023
If you'd like to deepen your understanding of complications in ST-segment elevation myocardial infarction, join the speakers as they present a series of cases focusing on atypical thrombus formation.
Heterotopic valve replacement for patients with right heart failure and tricuspid regurgitation - All you need to know!
17 May 2023 – From EuroPCR 2023
Discover the comprehensive guide to heterotopic valve replacement for patients experiencing right heart failure and tricuspid regurgitation. Join this session to gain insights into patient selection criteria, delve into the concept behind this innovative procedure, and grasp the fundamental aspects of its execution.
Complex PCI in high bleeding risk patients: adjust your strategy!
17 May 2023 – From EuroPCR 2023
With the guidance of a live case from the Clinique Pasteur in Toulouse - multivessel PCI in a patient at high bleeding risk- and the latest results from the MASTER DAPT randomized trial that enrolled patients treated exclusively with the Ultimater stent, the presenters invite us...
When dissection occurs during primary PCI
16 May 2023 – From EuroPCR 2023
Discover the complexities surrounding dissection during primary percutaneous coronary intervention (PCI). Immerse yourself in the challenges, implications and strategies employed to manage this critical scenario skillfully.
More pulses to take you further across all calcium morphologies
17 May 2023 – From EuroPCR 2023
Discover the latest insights on intravascular lithotripsy (IVL) for treating calcified lesions: explore its mechanism of action, technological advancements, and practical tips for challenging cases, including diffuse lesions, left main bifurcations, and eccentric/calcified nodules. Enhance your expertise in IVL with this concise and informative session!
The future of physiology- and morphology-guided PCI is optical!
17 May 2023 – From EuroPCR 2023
Join this session to explore the advantages of a fully optical approach in optimizing percutaneous coronary intervention (PCI) with the OptoWire III physiology wire and Nipro HF-OCT catheter. Through a practical case, you'll discover the significance of coronary physiology and intravascular imaging in bifurcation PCI and...
Calcified lesions: how to treat
16 May 2023 – From EuroPCR 2023
Learn more about the treatment of calcified lesions in this session, where speakers dissect a collection of cases focusing on tough situations.
Making treatment and management of complex PCIs easier with Cre8 EVO
17 May 2023 – From EuroPCR 2023
Maximize patient clinical outcomes in complex percutaneous coronary interventions (PCIs) by joining this session. Discover how accurate patient evaluation, advanced imaging/functional modalities, optimized procedures, and the Cre8 EVO device contribute to improved safety and efficacy, and review the challenges associated with DES implantation in complex PCIs.
PCR Valves e-Course: Sponsored Programme
EuroIntervention: Meet Cory, your new AI Assistant!
26 Mar 2024
Since the launch of its new website in February, EuroIntervention has harnessed the power of AI, integrating this cutting-edge technology in the development and improvement of features such as an optimised user interface and a powerful search engine.
All-new EuroPCR 2021: what’s on?
EuroPCR 2024 – Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial
15 May 2024
Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that will be presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical...
MERIL announces successful primary outcomes of next-gen Myval THV series in major RCT, presented at EuroPCR 2024 - Earns prestigious late Breaking trial status & The LANCET acceptance.
15 May 2024
Frequency and safety of bioprosthetic valve fracture in patients undergoing valve in valve TAVR for failed surgical valves using the SAPIEN 3/Ultra Valves: Insights from real-world data
19 Sep 2022
Michele Pighi provides his take on this trial which aimed to compare the safety and efficacy of VIV-TAVI with or without bioprosthetic valve fracture. It was presented by Santiago Garcia during the TCT Congress 2022.

Author
Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial
07 Apr 2024
REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.
Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...

Author

Author
When transfemoral TAVI is not an option: rethinking alternative access strategies
18 Jun 2026
In this article, Ulrich Schäfer explores the evolving landscape of access strategies in transcatheter aortic valve implantation (TAVI). While the transfemoral approach remains the gold standard, a significant proportion of patients are not suitable due to peripheral vascular disease or anatomical constraints.
Drawing on clinical evidence and...

Author
ILUMIEN IV: OPTIMAL PCI - Optical Coherence Tomography Guided Coronary Stent Implantation Compared with Angiography: A Multicenter Randomized Trial in Percutaneous Coronary Intervention
29 Aug 2023
Claudio Laudani and Daniele Giacoppo report the main results of the ILUMIEN IV trial presented by Ziad Ali, from the St. Francis Hospital, Roslyn, and Clinical Trials Center, Cardiovascular Research Foundation, New York, in a Hot Line session at the European Society of Cardiology congress 2023...

Author

Author